[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Harvey, 2020 - Google Patents

Cytolytic toxins

Harvey, 2020

Document ID
8550061560587616309
Author
Harvey A
Publication year
Publication venue
Handbook of toxinology

External Links

Snippet

This chapter summarizes information about cytolytic toxins. All cells have plasma membranes that act as a barrier between the internal environment of the cell and the extracellular fluid. It follows, therefore, that all cells are potential targets for cytolytic toxins …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Harvey Cytolytic toxins
Shier Handbook of toxinology
Dean Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover
Nagamune et al. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess
Butterworth The eosinophil and its role in immunity to helminth infection
Banks et al. Chemistry and pharmacology of honey-bee venom
Olivera et al. Peptide neurotoxins from fish-hunting cone snails
Warren et al. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor
ES2586125T3 (en) Staphylococcus aureus polypeptides and methods of use
CN102203127B (en) Leucoagglutinin and its application
Thiagarajan et al. In vitro attachment and invasion of chicken ovarian granulosa cells by Salmonella enteritidis phage type 8
JPH04506510A (en) Use of bactericidal/permeability-enhancing proteins or biologically active analogs thereof to treat lipopolysaccharide-associated gram-negative bacterial infections
DE69133485T2 (en) Use of Staphylococcal Enterotoxin Homologs for Cancer Therapy
IBRAHIM et al. Reproductive tract secretions and bull spermatozoa contain different clusterin isoforms that cluster cells and inhibit complement‐induced cytolysis
Boutin et al. Demonstration of invasiveness of Vibrio parahaemolyticus in adult rabbits by immunofluorescence
DE69329337T2 (en) ANTIBIOTIC CRYPTDINPEPTIDE AND METHODS OF USE
Page et al. Biosynthesis and glycosylation of serine/threonine-rich secreted proteins from Toxocara canis larvae
Coe Homologs of CRP: a diverse family of proteins with similar structure
Tosteson Mechanism of action, pharmacology, and toxicology
Wu Pharmacological actions of palytoxin
Minnick et al. Tissue site and modification of a bacteria-induced coagulation protein from Manduca sexta
Narat et al. The humoral and cellular immune response to a lipid attenuated pore-forming toxin from the sea anemone Actinia equina L.
Weed et al. Phenyl-Mercuric Compounds: Their Action on Animals and Their Preservative Values
CHUN Functional & structural studies of Stonustoxin (SNTX), a lethal factor from Stonefish (Synanceja Horrida) venom
JP4810638B2 (en) Antibacterial oligosaccharide and method for producing the same